Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban

Rivaroxaban: A New Oral Factor Xa Inhibitor

(2010) Elisabeth Perzborn et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Simplified Method for International Normalized Ratio (INR) Derivation Based on the Prothrombin Time/INR Line: An International Study

(2010) L. Poller et al.   CLINICAL CHEMISTRY

Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease

(2010) A. TRIPODI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study

(2010) A. TRIPODI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents

(2010) Julie Smith et al.   THROMBOSIS AND HAEMOSTASIS

An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

(2010) Jean Amiral et al.   THROMBOSIS AND HAEMOSTASIS

Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor

(2010) Jean-Luc Martinoli et al.   THROMBOSIS AND HAEMOSTASIS

New oral anticoagulants in development

(2009) J. I. Weitz   THROMBOSIS AND HAEMOSTASIS

Determination of rivaroxaban – a novel, oral, direct Factor Xa inhibitor – in human plasma by high-performance liquid chromatography–tandem mass spectrometry

(2008) G. Rohde   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES